Combined effects of two mutations in von Willebrand disease 2M phenotype
- Autores
- Woods, Adriana Inés; Paiva Palomino, Juvenal Hernán; Kempfer, Ana Catalina; Primrose, Debora Marina; Blanco, Alicia Noemi; Sánchez Luceros, Analía Gabriela; Lazzari, María Ángela
- Año de publicación
- 2018
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Background: Type 2M von Willebrand disease (VWD2M) is usually characterized byVWF:RCo/VWF:Ag<0.6 and normal multimeric profile; desmopressin (DDAVP) challengetest commonly shows poor response of VWF:RCo.Objective: We describe the bleeding tendency and the laboratory phenotype in a patient carrying two heterozygous mutations affecting VWF-A1 domain and VWF-A2domain.Subjects/methods: A 12-year-old patient (O blood group) with severe hemorrhagictendency was phenotypically and genotypically analyzed; his parents were alsostudied.Results: The proband showed decrease FVIII:C, VWF:RCo/VWF:Ag, and VWF:CB6/VWF:Ag ratios, but normal platelet count, VWF:CB1/VWF:Ag ratio, VWFpp and multimeric pattern, suggesting a VWD2M phenotype. The DDAVP challenge test, compared to controls (VWD2M patients with mutations in VWF-A1 domain), showed lower increase of FVIII:C and VWF:Ag than in heterozygous, but very similar to homozygous control. Two mutations were found in heterozygous and trans presentation: p.Pro1648fs*45 and a novel missense mutation, p.Arg1426Cys. The mother was p.Arg1426Cys heterozygous carrier, with few clinical symptoms. The father was asymptomatic, with no mutations. The p.Pro1648fs*45 was considered an apparent de novo mutation; proband?s AS-PCR revealed mosaicism in the paternal allele. According to the predicted models, p.Arg1426Cys would not be affecting the binding of GPIbα to A1 domain, whereas p.Pro1648fs*45 seems to modify the folding of A2 domain, and in this way, it would affect the binding to GPIbα and type VI collagen. We believe that the combination of these two heterozygous mutations, in a child with O blood group, could result in a defective phenotype enhancer.eCollection 2018 Jan
Fil: Woods, Adriana Inés. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; Argentina
Fil: Paiva Palomino, Juvenal Hernán. Academia Nacional de Medicina de Buenos Aires. Instituto de Investigaciones Hematológicas "Mariano R. Castex". Departamento de Hemostasia y Trombosis; Argentina
Fil: Kempfer, Ana Catalina. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; Argentina
Fil: Primrose, Debora Marina. Universidad de Morón. Facultad de Agronomía y Ciencias Agroalimentarias; Argentina
Fil: Blanco, Alicia Noemi. Academia Nacional de Medicina de Buenos Aires. Instituto de Investigaciones Hematológicas "Mariano R. Castex". Departamento de Hemostasia y Trombosis; Argentina
Fil: Sánchez Luceros, Analía Gabriela. Academia Nacional de Medicina de Buenos Aires. Instituto de Investigaciones Hematológicas "Mariano R. Castex". Departamento de Hemostasia y Trombosis; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; Argentina
Fil: Lazzari, María Ángela. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; Argentina - Materia
-
desmopressin
hemorrhage
mutations
type 2M
von Willebrand disease
von Willbrand factor - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc-nd/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/95515
Ver los metadatos del registro completo
id |
CONICETDig_75773b32aa65c500a2eb3f6093b9cdd1 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/95515 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Combined effects of two mutations in von Willebrand disease 2M phenotypeWoods, Adriana InésPaiva Palomino, Juvenal HernánKempfer, Ana CatalinaPrimrose, Debora MarinaBlanco, Alicia NoemiSánchez Luceros, Analía GabrielaLazzari, María Ángeladesmopressinhemorrhagemutationstype 2Mvon Willebrand diseasevon Willbrand factorhttps://purl.org/becyt/ford/3.2https://purl.org/becyt/ford/3Background: Type 2M von Willebrand disease (VWD2M) is usually characterized byVWF:RCo/VWF:Ag<0.6 and normal multimeric profile; desmopressin (DDAVP) challengetest commonly shows poor response of VWF:RCo.Objective: We describe the bleeding tendency and the laboratory phenotype in a patient carrying two heterozygous mutations affecting VWF-A1 domain and VWF-A2domain.Subjects/methods: A 12-year-old patient (O blood group) with severe hemorrhagictendency was phenotypically and genotypically analyzed; his parents were alsostudied.Results: The proband showed decrease FVIII:C, VWF:RCo/VWF:Ag, and VWF:CB6/VWF:Ag ratios, but normal platelet count, VWF:CB1/VWF:Ag ratio, VWFpp and multimeric pattern, suggesting a VWD2M phenotype. The DDAVP challenge test, compared to controls (VWD2M patients with mutations in VWF-A1 domain), showed lower increase of FVIII:C and VWF:Ag than in heterozygous, but very similar to homozygous control. Two mutations were found in heterozygous and trans presentation: p.Pro1648fs*45 and a novel missense mutation, p.Arg1426Cys. The mother was p.Arg1426Cys heterozygous carrier, with few clinical symptoms. The father was asymptomatic, with no mutations. The p.Pro1648fs*45 was considered an apparent de novo mutation; proband?s AS-PCR revealed mosaicism in the paternal allele. According to the predicted models, p.Arg1426Cys would not be affecting the binding of GPIbα to A1 domain, whereas p.Pro1648fs*45 seems to modify the folding of A2 domain, and in this way, it would affect the binding to GPIbα and type VI collagen. We believe that the combination of these two heterozygous mutations, in a child with O blood group, could result in a defective phenotype enhancer.eCollection 2018 JanFil: Woods, Adriana Inés. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; ArgentinaFil: Paiva Palomino, Juvenal Hernán. Academia Nacional de Medicina de Buenos Aires. Instituto de Investigaciones Hematológicas "Mariano R. Castex". Departamento de Hemostasia y Trombosis; ArgentinaFil: Kempfer, Ana Catalina. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; ArgentinaFil: Primrose, Debora Marina. Universidad de Morón. Facultad de Agronomía y Ciencias Agroalimentarias; ArgentinaFil: Blanco, Alicia Noemi. Academia Nacional de Medicina de Buenos Aires. Instituto de Investigaciones Hematológicas "Mariano R. Castex". Departamento de Hemostasia y Trombosis; ArgentinaFil: Sánchez Luceros, Analía Gabriela. Academia Nacional de Medicina de Buenos Aires. Instituto de Investigaciones Hematológicas "Mariano R. Castex". Departamento de Hemostasia y Trombosis; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; ArgentinaFil: Lazzari, María Ángela. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; ArgentinaWiley2018-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/95515Woods, Adriana Inés; Paiva Palomino, Juvenal Hernán; Kempfer, Ana Catalina; Primrose, Debora Marina; Blanco, Alicia Noemi; et al.; Combined effects of two mutations in von Willebrand disease 2M phenotype; Wiley; Research and Practice in Thrombosis and Haemostasis; 2; 1; 1-2018; 162-1672475-0379CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.1002/rth2.12067info:eu-repo/semantics/altIdentifier/url/https://onlinelibrary.wiley.com/doi/full/10.1002/rth2.12067info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-nd/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-17T11:51:38Zoai:ri.conicet.gov.ar:11336/95515instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-17 11:51:38.934CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Combined effects of two mutations in von Willebrand disease 2M phenotype |
title |
Combined effects of two mutations in von Willebrand disease 2M phenotype |
spellingShingle |
Combined effects of two mutations in von Willebrand disease 2M phenotype Woods, Adriana Inés desmopressin hemorrhage mutations type 2M von Willebrand disease von Willbrand factor |
title_short |
Combined effects of two mutations in von Willebrand disease 2M phenotype |
title_full |
Combined effects of two mutations in von Willebrand disease 2M phenotype |
title_fullStr |
Combined effects of two mutations in von Willebrand disease 2M phenotype |
title_full_unstemmed |
Combined effects of two mutations in von Willebrand disease 2M phenotype |
title_sort |
Combined effects of two mutations in von Willebrand disease 2M phenotype |
dc.creator.none.fl_str_mv |
Woods, Adriana Inés Paiva Palomino, Juvenal Hernán Kempfer, Ana Catalina Primrose, Debora Marina Blanco, Alicia Noemi Sánchez Luceros, Analía Gabriela Lazzari, María Ángela |
author |
Woods, Adriana Inés |
author_facet |
Woods, Adriana Inés Paiva Palomino, Juvenal Hernán Kempfer, Ana Catalina Primrose, Debora Marina Blanco, Alicia Noemi Sánchez Luceros, Analía Gabriela Lazzari, María Ángela |
author_role |
author |
author2 |
Paiva Palomino, Juvenal Hernán Kempfer, Ana Catalina Primrose, Debora Marina Blanco, Alicia Noemi Sánchez Luceros, Analía Gabriela Lazzari, María Ángela |
author2_role |
author author author author author author |
dc.subject.none.fl_str_mv |
desmopressin hemorrhage mutations type 2M von Willebrand disease von Willbrand factor |
topic |
desmopressin hemorrhage mutations type 2M von Willebrand disease von Willbrand factor |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/3.2 https://purl.org/becyt/ford/3 |
dc.description.none.fl_txt_mv |
Background: Type 2M von Willebrand disease (VWD2M) is usually characterized byVWF:RCo/VWF:Ag<0.6 and normal multimeric profile; desmopressin (DDAVP) challengetest commonly shows poor response of VWF:RCo.Objective: We describe the bleeding tendency and the laboratory phenotype in a patient carrying two heterozygous mutations affecting VWF-A1 domain and VWF-A2domain.Subjects/methods: A 12-year-old patient (O blood group) with severe hemorrhagictendency was phenotypically and genotypically analyzed; his parents were alsostudied.Results: The proband showed decrease FVIII:C, VWF:RCo/VWF:Ag, and VWF:CB6/VWF:Ag ratios, but normal platelet count, VWF:CB1/VWF:Ag ratio, VWFpp and multimeric pattern, suggesting a VWD2M phenotype. The DDAVP challenge test, compared to controls (VWD2M patients with mutations in VWF-A1 domain), showed lower increase of FVIII:C and VWF:Ag than in heterozygous, but very similar to homozygous control. Two mutations were found in heterozygous and trans presentation: p.Pro1648fs*45 and a novel missense mutation, p.Arg1426Cys. The mother was p.Arg1426Cys heterozygous carrier, with few clinical symptoms. The father was asymptomatic, with no mutations. The p.Pro1648fs*45 was considered an apparent de novo mutation; proband?s AS-PCR revealed mosaicism in the paternal allele. According to the predicted models, p.Arg1426Cys would not be affecting the binding of GPIbα to A1 domain, whereas p.Pro1648fs*45 seems to modify the folding of A2 domain, and in this way, it would affect the binding to GPIbα and type VI collagen. We believe that the combination of these two heterozygous mutations, in a child with O blood group, could result in a defective phenotype enhancer.eCollection 2018 Jan Fil: Woods, Adriana Inés. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; Argentina Fil: Paiva Palomino, Juvenal Hernán. Academia Nacional de Medicina de Buenos Aires. Instituto de Investigaciones Hematológicas "Mariano R. Castex". Departamento de Hemostasia y Trombosis; Argentina Fil: Kempfer, Ana Catalina. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; Argentina Fil: Primrose, Debora Marina. Universidad de Morón. Facultad de Agronomía y Ciencias Agroalimentarias; Argentina Fil: Blanco, Alicia Noemi. Academia Nacional de Medicina de Buenos Aires. Instituto de Investigaciones Hematológicas "Mariano R. Castex". Departamento de Hemostasia y Trombosis; Argentina Fil: Sánchez Luceros, Analía Gabriela. Academia Nacional de Medicina de Buenos Aires. Instituto de Investigaciones Hematológicas "Mariano R. Castex". Departamento de Hemostasia y Trombosis; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; Argentina Fil: Lazzari, María Ángela. Consejo Nacional de Investigaciones Científicas y Técnicas. Instituto de Medicina Experimental. Academia Nacional de Medicina de Buenos Aires. Instituto de Medicina Experimental; Argentina |
description |
Background: Type 2M von Willebrand disease (VWD2M) is usually characterized byVWF:RCo/VWF:Ag<0.6 and normal multimeric profile; desmopressin (DDAVP) challengetest commonly shows poor response of VWF:RCo.Objective: We describe the bleeding tendency and the laboratory phenotype in a patient carrying two heterozygous mutations affecting VWF-A1 domain and VWF-A2domain.Subjects/methods: A 12-year-old patient (O blood group) with severe hemorrhagictendency was phenotypically and genotypically analyzed; his parents were alsostudied.Results: The proband showed decrease FVIII:C, VWF:RCo/VWF:Ag, and VWF:CB6/VWF:Ag ratios, but normal platelet count, VWF:CB1/VWF:Ag ratio, VWFpp and multimeric pattern, suggesting a VWD2M phenotype. The DDAVP challenge test, compared to controls (VWD2M patients with mutations in VWF-A1 domain), showed lower increase of FVIII:C and VWF:Ag than in heterozygous, but very similar to homozygous control. Two mutations were found in heterozygous and trans presentation: p.Pro1648fs*45 and a novel missense mutation, p.Arg1426Cys. The mother was p.Arg1426Cys heterozygous carrier, with few clinical symptoms. The father was asymptomatic, with no mutations. The p.Pro1648fs*45 was considered an apparent de novo mutation; proband?s AS-PCR revealed mosaicism in the paternal allele. According to the predicted models, p.Arg1426Cys would not be affecting the binding of GPIbα to A1 domain, whereas p.Pro1648fs*45 seems to modify the folding of A2 domain, and in this way, it would affect the binding to GPIbα and type VI collagen. We believe that the combination of these two heterozygous mutations, in a child with O blood group, could result in a defective phenotype enhancer.eCollection 2018 Jan |
publishDate |
2018 |
dc.date.none.fl_str_mv |
2018-01 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/95515 Woods, Adriana Inés; Paiva Palomino, Juvenal Hernán; Kempfer, Ana Catalina; Primrose, Debora Marina; Blanco, Alicia Noemi; et al.; Combined effects of two mutations in von Willebrand disease 2M phenotype; Wiley; Research and Practice in Thrombosis and Haemostasis; 2; 1; 1-2018; 162-167 2475-0379 CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/95515 |
identifier_str_mv |
Woods, Adriana Inés; Paiva Palomino, Juvenal Hernán; Kempfer, Ana Catalina; Primrose, Debora Marina; Blanco, Alicia Noemi; et al.; Combined effects of two mutations in von Willebrand disease 2M phenotype; Wiley; Research and Practice in Thrombosis and Haemostasis; 2; 1; 1-2018; 162-167 2475-0379 CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/doi/10.1002/rth2.12067 info:eu-repo/semantics/altIdentifier/url/https://onlinelibrary.wiley.com/doi/full/10.1002/rth2.12067 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc-nd/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc-nd/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf application/pdf application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Wiley |
publisher.none.fl_str_mv |
Wiley |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1843606861642727424 |
score |
13.001348 |